Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project

OBJECTIVE: Loading dose of dual antiplatelet therapy (LD) is supported by the guidelines for patients with acute coronary syndrome (ACS). However, limited data is provided in the series of high bleeding risk (HBR) patients with ACS and percutaneous coronary intervention (PCI). METHODS: Using data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Gong, Wei, Huang, Xin, Li, Siyi, Wang, Ge, Ma, Youcai, Hao, Yongchen, Liu, Jun, Nie, Shaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984244/
https://www.ncbi.nlm.nih.gov/pubmed/35402551
http://dx.doi.org/10.3389/fcvm.2022.774123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984244/
https://www.ncbi.nlm.nih.gov/pubmed/35402551
http://dx.doi.org/10.3389/fcvm.2022.774123

Ejemplares similares